Back to JNJ Overview
NYQ · Valuation Lab
JNJ
Johnson & Johnson
Last$257.59
Market cap620.8B
EV/EBITDA18.4x
Intrinsic value
$242.17
MoS -6.4% · Fairly Valued
Assuming 17.2% FCF margin and 6.6% Y1–5 growth.
Upside to price
EV (DCF)611.9B
Terminal share73%
Expected IV$239.15
Probability weights
Projected free cash flows
Stage FCF path with present values · terminal 73% of EV
PV of stage FCFs165.9B
PV of terminal value446B
Enterprise value611.9B
Net cash / (debt)-28.3B
Equity value583.6B
Intrinsic value / share$242.17
| Year | Revenue | FCF | PV | DF |
|---|---|---|---|---|
| Y1 | 104.4B | 18B | 16.9B | 94.3% |
| Y2 | 111.3B | 19.1B | 17B | 89.0% |
| Y3 | 118.6B | 20.4B | 17.1B | 84.0% |
| Y4 | 126.5B | 21.8B | 17.2B | 79.2% |
| Y5 | 134.8B | 23.2B | 17.3B | 74.7% |
| Y6 | 139.3B | 24B | 16.9B | 70.5% |
| Y7 | 143.8B | 24.7B | 16.5B | 66.5% |
| Y8 | 148.6B | 25.6B | 16B | 62.7% |
| Y9 | 153.5B | 26.4B | 15.6B | 59.2% |
| Y10 | 158.6B | 27.3B | 15.2B | 55.8% |
| Terminal | — | — | 446B | — |
Educational DCF model only — not financial advice. Terminal value and assumptions dominate results; verify filings and run your own diligence.